tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Stock WebsitesTop Gainers/ Losers/ Active StocksDividend StocksChatGPT Stocks
ETFs
ETF CenterTop ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Crypto CenterBitcoin
Popular
Ethereum
Research Tools
Stock ScreenerETF Screener
Popular
Compare StocksCompare ETFsTrending StocksTechnical Analysis ScreenerPenny Stock ScreenerDaily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit CalculatorCompound Interest Calculator
New
Mortgage Calculator
New
Auto Loan Calculator
New
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Stock Websites
Top Gainers/ Losers/ Active Stocks
Dividend Stocks
ChatGPT Stocks
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Research Tools
Stock Screener
ETF Screener
Popular
Compare Stocks
Compare ETFs
Trending Stocks
Technical Analysis Screener
Penny Stock Screener
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compound Interest Calculator
New
Mortgage Calculator
New
Auto Loan Calculator
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Enterprise Solutions
Plans & Pricing
Education
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
US Market
MLTX
MoonLake Immunotherapeutics
Stock Analysis
Analyst Forecasts
Technical Analysis
Options
New
Chart
Earnings
Dividends
Ownership
Financials
News & Insights
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

MoonLake Immunotherapeutics (MLTX) Stock News & Sentiment

85 Followers
MoonLake announces full dataset from 24-week MIRA clinical trial
The FlyMoonLake announces full dataset from 24-week MIRA clinical trial
4d ago
MLTX
MoonLake Immunotherapeutics announces the full dataset from its 24-week MIRA clinical trial, establishing the Nanobody® sonelokimab as a highly promising and differentiated therapeutic solution for Hidradenitis Suppurativa
Press ReleasesMoonLake Immunotherapeutics announces the full dataset from its 24-week MIRA clinical trial, establishing the Nanobody® sonelokimab as a highly promising and differentiated therapeutic solution for Hidradenitis Suppurativa
4d ago
MLTX
MoonLake Immunotherapeutics presents positive 12-week data from the Phase 2 MIRA trial with Nanobody® Sonelokimab for Hidradenitis Suppurativa at the European Academy of Dermatology and Venereology Congress
Press ReleasesMoonLake Immunotherapeutics presents positive 12-week data from the Phase 2 MIRA trial with Nanobody® Sonelokimab for Hidradenitis Suppurativa at the European Academy of Dermatology and Venereology Congress
8d ago
MLTX
MoonLake Immunotherapeutics presents 12-week data from Phase 2 MIRA trial
The FlyMoonLake Immunotherapeutics presents 12-week data from Phase 2 MIRA trial
8d ago
MLTX
Insider Trading: Major Owner at MoonLake (NASDAQ:MLTX) Continues to Grow Stake
Market NewsInsider Trading: Major Owner at MoonLake (NASDAQ:MLTX) Continues to Grow Stake
8d ago
MLTX
Beneficial owner of MoonLake Immunotherapeutics Bihua Chen buys $17M in shares
The FlyBeneficial owner of MoonLake Immunotherapeutics Bihua Chen buys $17M in shares
13d ago
MLTX
MoonLake Immunotherapeutics to present Phase 2 MIRA trial data for sonelokimab
The FlyMoonLake Immunotherapeutics to present Phase 2 MIRA trial data for sonelokimab
15d ago
MLTX
More MLTX News >

MLTX News on the Web

Does MoonLake Immunotherapeutics (MLTX) Have What it Takes to be in Your Portfolio Wednesday?
Investors Observer
Neutral
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Black Diamond Therapeutics (BDTX), Omnicell (OMCL) and MoonLake Immunotherapeutics (MLTX)
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Acasti Pharma (ACST), Omnicell (OMCL) and MoonLake Immunotherapeutics (MLTX)
TipRanks News
Neutral
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Neutral
Analysts Conflicted on These Healthcare Names: Clover Health Investments (CLOV), MoonLake Immunotherapeutics (MLTX) and Relay Therapeutics (RLAY)
TipRanks News
Neutral
Promising Efficacy and Safety Profile of Sonelokimab in Hidradenitis Suppurativa: An Analysis of Buy Rating for MoonLake Immunotherapeutics
TipRanks News
Neutral
MoonLake Immunotherapeutics' Lead Skin Disorder Candidate Continues to Deliver on Best-Efficacy Profile
Yahoo Finance
Neutral

News Score - Last 7 Days

Very Positive
MLTX
Sector Average
Media Buzz
This Week14 articles
Weekly Average6.75 articles
News Sentiment
This Week100%
Sector Average62%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MLTX’s Media Buzz Sentiment?
14 articles about MLTX were published this week. In an average week, 6.75 articles are published.
    What is MLTX’s weekly average amount of articles?
    In an average week, 6.75 articles about MLTX are published.
      What is MLTX’s News Sentiment?
      100% of articles about MLTX were positive this week, compared to its sector average of 62%.
        Healthcare Stocks that are Trending in the News
        OPRXOptimizeRx
        VERAVera Therapeutics
        HALOHalozyme
        PROKProKidney
        JNJJohnson & Johnson
        Showing the stocks with the most bullish news sentiment over the past week

        Get More with TipRanks Premium

        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing